Samsung Biologics bags $1.24bn CDMO contract with Asia-based pharma firm
Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), has signed its largest-ever contract, valued at USD 1.24 billion, with an undisclosed ... Read More
Sartorius to invest €270m to expand South Korea operations
Sartorius, a German pharma and lab equipment supplier, said that it is investing nearly €270 million through 2024 for expanding its operations in South Korea. ... Read More